
Peter Haggert
@peterhaggert
Peter Haggert | haggertmedia.com | Dynamics Recruitment | News Consumer Insights Program Manager NA Google | CLL healthcare advocate - CLL Canada/CLLAN
ID: 15802601
http://www.haggertmedia.com 10-08-2008 23:35:23
281 Tweet
451 Takipçi
1,1K Takip Edilen



Particularly impressive results for zilovertamab + ibrutinib in chronic lymphocytic leukaemia (CLL), especially in patients with TP53 mutations, who had a PFS of 100% at median follow up of 42 months Michael Wang, MD #lymsm #ASH22







Saved Against Her Will . A deep look at Do Not Rescucitate orders 100r.org/2024/08/saved-… via 100Reporters




“In CLL CANADA, we strive for better relationships with haematologists, who can call on us to help guide the newly diagnosed to understand the disease and guide patients to a more thorough understanding of their diagnosis” - Peter Haggert #WCLLD24 #LetsLevelUp #CLL






